Isolated thrombocytosis as first sign of chronic myeloid leukemia with e6a2 BCR/ABL fusion transcript, JAK2 negativity and complete response to imatinib

Leukemia Research

Volumn 32, Issue 1, 2008, Pages 177-180

  Breccia, Massimo ^a   Cannella, Laura ^a   Diverio, Daniela ^a   Streponi, Paola ^b   Nanni, Mauro ^a   Stefanizzi, Caterina ^a   Natalino, Fiammetta ^a   Mecarocci, Sergio ^a   Alimena, Giuliana ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Chronic myeloid leukemia; e6a2 transcript; Imatinib

Indexed keywords

BCR ABL PROTEIN; E6A2 BCR ABL PROTEIN; IMATINIB; JANUS KINASE 2; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE REPORT; CHROMOSOME ANALYSIS; CHRONIC MYELOID LEUKEMIA; CLINICAL FEATURE; DRUG RESPONSE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; KARYOTYPE; LEUKOCYTE COUNT; LEUKOPENIA; MALE; ONCOGENE; PRIORITY JOURNAL; PROGNOSIS; SYMPTOM; THROMBOCYTE COUNT; THROMBOCYTOSIS;

ADULT; CHROMOSOME BREAKAGE; HUMANS; JANUS KINASE 2; LEUKEMIA, MYELOID, CHRONIC, ATYPICAL, BCR-ABL NEGATIVE; MALE; PIPERAZINES; PYRIMIDINES; THROMBOCYTOSIS; TREATMENT OUTCOME;

EID: 36048941357     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2007.05.022     Document Type: Article

References (16)

1. Melo J.V. The molecular biology of chronic myeloid leukaemia. Leukemia 10 (1996) 751-756
2. Daley G.Q., Van Etten R.A., and Baltimore D. Induction of chronic myelogenous leukemia in mice by the P210 bcr/abl gene of the Philadelphia chromosome. Science 247 (1990) 824-830
3. Bose S., Deininger M., Gora-Tybor J., Goldman J.M., and Melo J.V. The presence of typical and atypical BCR/ABL fusion genes in leukocytes of normal individuals: biologic significance and implications for the assessment of minimal residual disease. Blood 92 (1998) 3362-3367
4. Hayette S., Tigaud I., Thomas X., French M., Perrin M.C., Nicolini F., et al. Identification of a rare e6a2 BCR-ABL fusion gene during the disease progression of chronic myelomonocytic leukaemia: a case report. Leukemia 18 (2004) 1735-1736
5. Quentmeier H., Cools J., MacLeod R.A.F., Marynen P., Uphoff C.C., and Drexler H.G. E6a2 BCR/ABL1 fusion in T-cell acute lymphoblastic leukaemia. Leukemia 19 (2005) 295-296
6. Hochhaus A., Reiter A., Skladny H., Melo J.V., Sick C., Berger U., et al. A novel BCR-ABL fusion gene (e6a2) in a patient with Philadelphia chromosome-negative chronic myelogenous leukaemia. Blood 88 (1996) 2236-2240
7. Dupont M., Jourdan E., and Chiesa J. Identification of e6a2 BCR-ABL fusion in a Philadelphia-positive CML. Leukemia 14 (2000) 2011-2012
8. Schulteis B., Wang L., Clark R.E., and Melo J.V. BCR-ABL with an e6a2 fusion in a CML patient diagnosed in blast crisis. Leukemia 17 (2003) 2054-2055
9. Colla S., Sammarelli G., Voltolini S., Crugnola M., Sebastio P., and Giuliani N. e6a2 BCR-ABL transcripts in chronic myeloid leukemia: it is associated with aggressive disease?. Haematologica 89 (2004) 611-613
10. Roti G., La Starza R., Gorello P., Gottardi E., Crescenzi B., Martelli M.F., et al. e6a2 BCR/ABL1 fusion with criptic der(9) t(9; 22) deletions in a patient with chronic myeloid leukemia. Haematologica 90 (2005) 1139-1141
11. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Ann Biochem 162 (1987) 156-159
12. van Dongen J.J., Macintyre E.A., Gabert J.A., et al. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia. Leukemia 13 (1999) 1901-1928
13. Baxter E.J., Scott L.M., Campbell P.J., East C., Fourouclas N., Swanton S., et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 365 (2005) 1054-1061
14. Branford S., Rudzki Z., and Hughes T.P. A novel BCR-ABL transcript (e8a2) with the insertion of an inverted sequence of ABL intron 1b in a patient with Philadelphia positive chronic myeloid leukaemia. Br J Haematol 109 (2000) 635-637
15. Moreno M., del P., Cortinas M.N., Bonomi R., Cardeza A., Uriarte M., et al. A novel BCR-ABL fusion transcript (e15a2) in 2 patients with atypical chronic myeloproliferative syndrome. Blood 97 (2001) 3668-3669
16. Laurent E., Talpaz M., Kantarjian H.M., and Kurzrock R. The BCR gene and Philadelphia chromosome-positive leukemogenesis. Cancer Res 61 (2001) 2343-2355